Renal Cell Carcinoma

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Colleague Insights

Cost-Effectiveness of First-Line Lenvatinib Plus Pembrolizumab or Everolimus vs Sunitinib for Advanced RCC

Clin Genitourin Cancer · January 03, 2023
story of the week

Frontline ICI-Based Combination Therapy in Patients With Metastatic RCC With Poor Performance Status

Eur. J. Cancer · January 02, 2023

1 Expert Comment
Prognostic Implication of PD-L1 Expression in Recurrent RCC Following Nephrectomy

Int. J. Clin. Oncol. · December 29, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic RCC Treated With Everolimus in a Pre-Nephrectomy Setting

Clin Oncol (R Coll Radiol) · December 28, 2022
story of the week

Perioperative Morbidity Associated With Metastasectomy in Patients With Renal Cell Carcinoma

Eur Urol Oncol · December 27, 2022

1 Expert Comment
story of the week

Efficacy and Safety of Vorolanib Plus Everolimus in mRCC

Eur. J. Cancer · December 21, 2022
Long-Term Clinical Outcomes of a Cohort of Spanish Patients Diagnosed With mRCC With a Complete Response to Sunitinib

Clin Genitourin Cancer · December 20, 2022
featured

The Natural History of RCC With Sarcomatoid Differentiation

Clin Genitourin Cancer · December 19, 2022
story of the week

Long-Term (5-Year) Outcomes of Stereotactic Ablative Body Radiotherapy in Patients With Primary Renal Cell Carcinoma

Lancet Oncol · December 15, 2022
featured

Role of Epigenetic Alterations on Response and Resistance to Immune Checkpoint Inhibitors in ccRCC

Clin. Cancer Res · December 14, 2022

Renal Cell Carcinoma Faculty

Our virtual center of excellence in the treatment of renal cell carcinoma leverages technology to create a collaborative and comprehensive way to improve patient care. This unique center has the key advantages of a real world academic center as well as the features and enhancements that only PracticeUpdate and Elsevier can provide to foster an expert-led team approach that helps you stay ahead.

Editor-in-Chief

Sumanta Kumar Pal MD

Associate Editor

Jun Gong MD

Advisory Board

Eric Jonasch MD

Editorial Contributor

Nazli Dizman MD

JoAnn Hsu

Kamal Sahu MD

George Yaghmour MD